Ind-Swift Laboratories said that its board will meet on Thursday, 27 June 2024 to raise funds by issuing one or more instruments through various modes.
The companys board will meet to consider and approve the proposal for raising of funds by way of issuance of one or more instruments including equity shares/ convertible securities either by way of preferential issue/ rights issue/ QIP/ or any other mode as may be consideredInd-Swift Laboratories is engaged in manufacturing pharmaceutical products especially active pharmaceutical ingredients (APIs) & advanced intermediates.
The company reported consolidated net profit of Rs 238.82 crore in Q4 FY24 as compared with net loss of Rs 25.12 crore in Q4 FY23. Revenue from operations jumped 29.3% YoY to Rs 393.33 crore in Q4 FY24.
The scrip rose 1.89% to settle at Rs 118.70 on Monday, 24 June 2024.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app